The recruitment of exogenous endothelial progenitor cells in lung tumor model of nude mice

Chinese Journal of Cancer

Volumn 29, Issue 11, 2010, Pages 952-958

  Peng, Qiang ^a   Liu, Ming ^a   Song, Shu Min ^a   Li, Xian Hua ^b   Du, Yi Hua ^a   Zhi, Yong ^a   Wang, Min Yong ^b  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial progenitor cell; Exogenous; Nude mice; Recruitment; Tumor

Indexed keywords

CD133 ANTIGEN; GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 79955793241     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10194     Document Type: Article

References (25)

1. Hall MA, Jane SM, Green AR, et al. Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium [J]. Blood, 2004, 104(6): 1769-1777.
2. De Palma M, Venneri MA, Roca C, et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells [J]. Nat Med, 2003, 9(6): 789-795.
3. He Y, Rajantie I, Ilmonen M, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymph angiogenesis and lymphatic metastasis [J]. Cancer Res, 2004, 64(11): 3737-3740.
4. Kopp HG, Ramos CA, Rafii S, et al. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue [J]. Curr Opin Hematol, 2006, 13(3): 175-181.
5. Hattori K, Ishihara M, Heissig B. Bone marrow-derived cells contribute to niche formation in cancer progression [J]. Clin Calcium, 2008, 18(4): 480-487.
6. Yi AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells [J]. Blood, 1997, 90(12): 5002-5012.
7. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by exogenous human CD34 (+) cells identifies a population of functional endothelial precursors [J]. Blood, 2000, 95(3): 952-958.
8. Min JH, Yang H, Ivan M, et al. Structure of an HIF-lalpha-pVHL complex: hydroxyproline recognition in signaling [J]. Science, 2002, 296(5): 1886-1889.
9. Giatromanolaki A, Arvanitidou V, Hatzimichael A, et al. The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas [J]. Pathology, 2005, 37(2): 149-151.
10. Gu YZ, Moran SM, Hogenesch JB, et al. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3-alpha [J]. Gene Expr, 1998, 7(3): 205-213.
11. Buchler P, Reber HA, Buchler MW, et al. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia inducible factor-1 and the down regulation of VEGF gene expression [J]. Cancer, 2004, 100(1): 201-210.
12. Semenza GL. Targeting HIF-1 for cancer therapy [J]. Nat Rev Cancer, 2003, 3(10): 721-732.
13. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue [J]. Trends Cardiovasc Med, 2005, 15(2): 57-63.
14. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 [J]. Nat Med, 2004, 10(8): 858-864.
15. Nomura R, Yoshida D, Teramoto A. Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia [J]. J Neurooncol, 2009, 94(2): 173-181.
16. Arbab AS, Janic B, Knight RA, et al. Detection of migration of locally implanted AC133 + stem cells by cellular magnetic resonance imaging with histological findings [J]. FASEB J, 2008, 22(9): 3234-3246.
17. Rafii S, Heissig B, Hattori K, et al. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors [J]. Gene Ther, 2002, 9(10): 631-641.
18. Nolan DJ, Ciarrocchi A, Mellick AS, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization [J]. Genes Dev, 2007, 21(12): 1546-1558.
19. Reddy K, Zhou Z, Jia SF, et al. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor [J]. Int J Cancer, 2008, 123(4): 831-837.
20. Aghi M, Cohen KS, Klein RJ, et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes [J]. Cancer Res, 2006, 66(18): 9054-9064.
21. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bonemarrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth [J]. Nat Med, 2001, 7(11): 1194-1201.
22. Arafat WO, Casado E, Wang M, et al. Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells [J]. Clin Cancer Res, 2000, 6(11): 4442-4448.
23. Muta M, Matsumoto G, Hiruma K, et al. Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model [J]. Oncol Rep, 2003, 10(6): 1765-1769.
24. Debatin KM, Wei J, Beltinger C. Endothelial progenitor cells for cancer gene therapy [J]. Gene Ther, 2008, 15(10): 780-786.
25. Peled A, Grabovsky V, Habler L, et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34 (+) cells on vascular endothelium under shear flow [J]. J Clin Invest, 1999, 104(9): 1199-1211.